These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

497 related items for PubMed ID: 6934088

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Pharmacokinetics of sustained release and conventional tablets of theophylline plus hydroxyethyltheophylline and its comparison with tablet aminophylline.
    Gupta S, Raina RK, Samotra K, Gupta KL.
    Indian J Chest Dis Allied Sci; 1991; 33(1):1-8. PubMed ID: 1791015
    [Abstract] [Full Text] [Related]

  • 23. A comparison of steady state plasma theophylline concentrations with conventional and sustained release formulations.
    Mellstrand T, Svedmyr K, Svedmyr N.
    Eur J Respir Dis; 1982 Jan; 63(1):31-4. PubMed ID: 7040098
    [Abstract] [Full Text] [Related]

  • 24. Bioavailability of sustained-release theophylline formulations.
    Bonora Regazzi M, Rondanelli R, Vidale E, Cristiani D.
    Int J Clin Pharmacol Ther Toxicol; 1983 May; 21(5):245-51. PubMed ID: 6862729
    [Abstract] [Full Text] [Related]

  • 25. Comparative absorption of theophylline following multiple doses of a sustained-release formulation and an elixir in humans.
    Harrison LI, French IW, Mildon CA.
    Clin Ther; 1982 May; 4(6):489-96. PubMed ID: 7093982
    [Abstract] [Full Text] [Related]

  • 26. [Comparison of circadian variation of serum theophylline concentration and bioavailability between Theo-dur tablet and a new sustained-release theophylline formulation (E-0686 granule)].
    Kishida M, Okuma M, Uekusa T, Akimoto K, Obata T, Akazawa A, Odajima Y, Nagakura T, Iikura Y, Hukushima K.
    Arerugi; 1988 Apr; 37(4):218-25. PubMed ID: 3228360
    [No Abstract] [Full Text] [Related]

  • 27. [Release, absorption and elimination of theophylline from fast and slowly released oral formulations].
    Frömming KH, Schwabe L, Staib AH, Rietbrock N, Lassmann A, Molz KH, Schuppan D, Siebert-Weigel M, Voegele D.
    Arzneimittelforschung; 1983 Apr; 33(3):446-52. PubMed ID: 6683521
    [Abstract] [Full Text] [Related]

  • 28. A cross-over study of oral and intravenous administration of theophylline in male volunteers. Absolute bioavailability of theophylline tablets.
    Kaumeier HS, Kehrhahn OH, Neugebauer G, Schuppan D, Schwarz JA, Staib AH.
    Arzneimittelforschung; 1984 Apr; 34(1):92-5. PubMed ID: 6538428
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Study of bioavailability and pharmacokinetics of theophylline following administration of two sustained release dosage forms as assessed by salivary data: Part II.
    Ohmori N, Inotsume N, Matsukura M, Higashi A, Iwaoku R, Tobino Y, Nakano M, Matsuda I.
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):196-201. PubMed ID: 3710632
    [Abstract] [Full Text] [Related]

  • 32. Differences in steady-state plasma levels between aminophylline and theophylline sustained-release micropellets after repeated circadian dosing.
    Schulz HU, Steinijans VW, Gabel H.
    Int J Clin Pharmacol Ther Toxicol; 1984 Nov; 22(11):621-5. PubMed ID: 6500759
    [Abstract] [Full Text] [Related]

  • 33. Comparison of Theolair SR and Theo-Dur tablets.
    Domson JF, Hein EW, Sheen A, Sly RM.
    Ann Allergy; 1979 Oct; 43(4):220-2. PubMed ID: 555598
    [Abstract] [Full Text] [Related]

  • 34. Conversion from intravenous to oral dosing using sustained-release theophylline tablets.
    Stein GE, Haughey DB, Ross RJ, Vakoutis J.
    Drug Intell Clin Pharm; 1982 Oct; 16(10):772-4. PubMed ID: 7140514
    [Abstract] [Full Text] [Related]

  • 35. Evaluation of serum theophylline concentrations following administration of sustained-release beads in applesauce to asthmatic preschool children.
    Leeder JS, Robertson C, Correia J, Isles AF, Levison H, Macleod SM.
    Ann Allergy; 1986 Feb; 56(2):133-7. PubMed ID: 3946845
    [Abstract] [Full Text] [Related]

  • 36. Therapeutic equivalence of a generic slow-release theophylline tablet.
    Hendeles L, Breton AL, Beaty R, Harman E.
    Pharmacotherapy; 1995 Feb; 15(1):26-35. PubMed ID: 7739942
    [Abstract] [Full Text] [Related]

  • 37. Bioavailability, efficacy, and tolerance of two sustained-release theophylline dosage forms in adult patients with bronchial asthma.
    Trautlein JJ, Demers L, Esler V, Field E.
    Clin Ther; 1981 Feb; 4(4):252-62. PubMed ID: 7332913
    [Abstract] [Full Text] [Related]

  • 38. Absorption properties of two theophylline sustained-release products in smokers.
    Miller R, Rheeders M.
    S Afr Med J; 1984 Jun 30; 65(26):1045-8. PubMed ID: 6740419
    [Abstract] [Full Text] [Related]

  • 39. Rapid and sustained oral theophylline loading. An alternative to intravenous aminophylline therapy.
    Brown DL, Maddux MS, Organek HW, Bauman JL.
    Arch Intern Med; 1983 Apr 30; 143(4):794-6. PubMed ID: 6838301
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 25.